Immunologist of the Month
Every month we feature a new interview with an Immunologist. These Immunologists are at the cutting-edge of research and education, they have kindly offered to give us their time and insight into their research and studies.
August 2024
Dr Tracey J. Lamb, PhD is a notable researcher in the field of malaria. Dr. Lamb’s educational background includes a B.Sc. from the University of Glasgow, Scotland, and a Ph.D. from the University of Edinburgh, Scotland. Her work focuses on understanding the immunopathogenesis of infectious diseases. Tracey holds the position of Professor of Pathology at the Department of Pathology, University of Utah, USA where she is also the Director of the Microbiology and Immunology Graduate Program.
Read more – Tracey J. Lamb
July 2024
The Director of Immunopaedia, Clive Gray, winner of the 2023 Harry Oppenheimer Fellowship was presented with the award in July 2024. He will use the fellowship to investigate events in the placenta related to angiogenesis and identify a biomarker that can predict premature birth as well as understand how the placenta functions to ensure the health and well-being of both infant and mother. Professor Gray currently heads the Reproductive Immunology Research Consortium in Africa (RIRCA) at Stellenbosch University. This is a consortium of immunologists and paediatricians conducting research into markers and mechanisms of poor birth and perinatal outcomes, with a focus on children who are born to mothers with HIV and other infectious diseases.
Read more – Clive Gray
June 2024
Professor Dieter Kabelitz is an eminent immunologist with an impressive career spanning over 30 years. He served as a full professor at the University of Kiel and was the director of the Institute of Immunology from 1999 to 2018. Dieter continued his career as a senior research group leader at the Institute for Immunology of the University Hospital Schleswig-Holstein Institute of Immunology (UKSH) at the University of Kiel, Germany. He focuses on the functional characterization of γδ T cells. Specifically, he explores strategies to enhance the effector functions of these cells for potential use in cancer immunotherapy. Prof. Kabelitz has been involved in several educational and scientific organizations, including serving as the president of the German Society for Immunology and as a council member of the International Union of Immunological Societies (IUIS). Dieter is currently the past-Chair of the IUIS Education Committee, and he has been involved in building IUIS courses for many years.
Read more – Dieter Kabelitz
